Her primary scientific interests are in Cancer, Antigen, Immunology, Stereochemistry and Cancer research. In general Cancer, her work in Breast cancer and Cancer treatment is often linked to Protocol design linking many areas of study. Her study focuses on the intersection of Antigen and fields such as Immune system with connections in the field of Antibody.
Her research investigates the connection between Immunology and topics such as Telomerase reverse transcriptase that intersect with problems in Cellular immunity. Her Stereochemistry research includes themes of Tryptophan synthase, Biochemistry, Serine and Active site. Her research in Cancer research focuses on subjects like Cancer cell, which are connected to CD44, Interleukin 4, Cell adhesion, Metastasis and CCL18.
Karen S. Anderson mainly investigates Breast cancer, Internal medicine, Cancer, Immunology and Antigen. Within one scientific family, Karen S. Anderson focuses on topics pertaining to Cancer research under Breast cancer, and may sometimes address concerns connected to Cell. In her work, Neoadjuvant therapy is strongly intertwined with Oncology, which is a subfield of Internal medicine.
Her biological study spans a wide range of topics, including Molecular biology and Pathology. Her work deals with themes such as Biochemistry and Enzyme, which intersect with Molecular biology. Her Antigen research is multidisciplinary, relying on both Autoantibody, Antibody, Cytotoxic T cell and Protein microarray.
Her primary areas of study are Breast cancer, Internal medicine, Cancer research, Oncology and Disease. Her Breast cancer research is classified as research in Cancer. The study incorporates disciplines such as Myxoma virus and Multiplicity of infection in addition to Cancer.
Her Cancer research study integrates concerns from other disciplines, such as Duodenal Carcinoma, DNA mismatch repair, Renal cell carcinoma and Immunotherapy. She focuses mostly in the field of Immunotherapy, narrowing it down to matters related to Surgical oncology and, in some cases, Epitope. Karen S. Anderson has researched Oncology in several fields, including Neoadjuvant therapy, Neo adjuvant, Autoantibody, Mammography screening and Early detection.
Karen S. Anderson spends much of her time researching Breast cancer, Internal medicine, Epitope, Oncology and Genetics. Karen S. Anderson is interested in Breast biopsy, which is a branch of Breast cancer. Her Internal medicine research integrates issues from Exome sequencing and Autoantibody.
Karen S. Anderson has included themes like Virology, T cell, CD8, Immunogenicity and Human leukocyte antigen in her Epitope study. The Oncology study combines topics in areas such as Neoadjuvant therapy, Breast imaging, Disease, Biomarker and Bi rads 3. Her Disease research includes elements of Neoplasm, Cancer, Circulating tumor DNA and Complete response.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Molecular Definition of Breast Tumor Heterogeneity
Michail Shipitsin;Lauren L. Campbell;Pedram Argani;Stanislawa Weremowicz.
Cancer Cell (2007)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
Lauren L.C. Marotta;Vanessa Almendro;Vanessa Almendro;Andriy Marusyk;Michail Shipitsin.
Journal of Clinical Investigation (2011)
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Jingqi Chen;Jingqi Chen;Yandan Yao;Chang Gong;Fengyan Yu.
Cancer Cell (2011)
Presentation of viral antigen controlled by a gene in the major histocompatibility complex.
V Cerundolo;J Alexander;K Anderson;C Lamb.
Toxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase
Allison A. Johnson;Adrian S. Ray;Jeremiah W. Hanes;Zucai Suo.
Journal of Biological Chemistry (2001)
The Sentinel Within: Exploiting the Immune System for Cancer Biomarkers†
Karen S. Anderson;Joshua LaBaer.
Journal of Proteome Research (2005)
Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner
Matthew J. Androlewicz;Karen S. Anderson;Peter Cresswell.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Dose-response Curve Slope Sets Class-Specific Limits on Inhibitory Potential of Anti-HIV Drugs
Lin Shen;Susan Peterson;Ahmad R Sedaghat;Moira A McMahon.
Nature Medicine (2008)
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.
Robert H. Vonderheide;Susan M. Domchek;Joachim L. Schultze;Daniel J. George.
Clinical Cancer Research (2004)
Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study.
Al B. Benson;Janet Prokop Pregler;Judy A. Bean;Alfred W. Rademaker.
Journal of Clinical Oncology (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: